Latest Breaking News On - Adrienne farid - Page 1 : comparemela.com

Century Therapeutics, Inc (NASDAQ:IPSC) Short Interest Update

Century Therapeutics, Inc (NASDAQ:IPSC) Short Interest Update
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Adrienne faridPiper sandlerCentury therapeutics company profileMabel hallJacobs levy equity management incCanaccord genuity groupCentury therapeutics incMirae asset global investments coHermes incCentury therapeuticsGet free reportGenuity groupAsset global investmentsLevy equity managementAvidity partners managementPartners management

Q1 2025 Earnings Estimate for Century Therapeutics, Inc Issued By HC Wainwright (NASDAQ:IPSC)

Q1 2025 Earnings Estimate for Century Therapeutics, Inc Issued By HC Wainwright (NASDAQ:IPSC)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerAdrienne faridHermes incMirae asset global investments coCentury therapeutics company profileSecurities exchange commissionCentury therapeutics incVanguard group incCanaccord genuity groupMabel hallCentury therapeuticsFree reportCentury therapeuticGet free reportGenuity groupPartners management

Analysts Set Century Therapeutics, Inc (NASDAQ:IPSC) PT at $14 17

Analysts Set Century Therapeutics, Inc (NASDAQ:IPSC) PT at $14 17
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerAdrienne faridCanaccord genuity groupBarclays plcWells fargo companyCitigroup incCentury therapeutics incSecurities exchange commissionCentury therapeuticsGet free reportGenuity groupExchange commissionPublic employees retirement systemGet freeCentury therapeutics daily

Century Therapeutics, Inc (NASDAQ:IPSC) Given Consensus Recommendation of Moderate Buy by Brokerages

Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 […]

Adrienne faridCentury therapeutics incMabel hallVirtu financialVanguard group incCentury therapeutics company profileBarclays plcCanaccord genuity groupSecurities exchange commissionCentury therapeuticsGet free reportMarketbeat ratingsGenuity groupExchange commissionAvidity partners managementPartners management

Century Therapeutics, Inc (NASDAQ:IPSC) Receives Average Recommendation of Moderate Buy from Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among […]

Adrienne faridCentury therapeutics company profileCanaccord genuity groupBlackrock incHermes incCentury therapeutics incSecurities exchange commissionVanguard group incCentury therapeuticsGet free reportMarketbeat ratingsGenuity groupTherapeutics stock downExchange commissionPartners managementState street corp